Eculizumab for pregnancy associated atypical hemolytic uremic syndrome: a retrospective study in 85 patients

Korotchaeva Y.V.: Sechenov University, Moscow

Kozlovskaya N.L.: Eramishancev City Clinical Hospital, Moscow

Shifman E.M.: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia

Moiseev S.: Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia

Download in PDF

Summary

Aim

To evaluate the efficacy of prompt and delayed complement inhibition therapy with eculizumab in patients with pregnancy associated atypical hemolytic uremic syndrome (aHUS).